Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Due to limited data on the pathogenesis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and the suboptimal therapeutic effect, the development of new and effective treatment modalities was needed urgently. Low‐intensity extracorporeal shock wave therapy (Li‐ESWT) has been reported for the treatment of CP/CPPS. However, the underlying mechanism remains to be elucidated.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To interrogated the efficacy and the mechanism of Li‐ESWT in the treatment of CP/CPPS.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>According to different treatments, RWPE‐1 cells (human prostate epithelial cells) were randomly divided into three groups: control group, LPS(lipopolysaccharide) group, or Li‐ESWT group (LPS induced RWPE‐1 managed by Li‐ESWT). Following the Li‐ESWT treatment, the levels of oxidative stress was assayed. We then established a rat model of experimental autoimmune prostatitis (EAP) by injecting prostatic protein homogenate mixed with complete Freund's adjuvant. The Sprague‐Dawley rats were randomly divided into the control group, EAP group, or Li‐ESWT group. Von Frey Filament was used to quantify pelvic hyperalgesia in the rats. Prostates tissues from each group were collected for immunohistochemistry, oxidation stress, and western blot analysis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Histological analysis showed reduced inflammation and expression of cytokines (TNF‐α, IL‐1β, IL‐6, COX‐2, SP) in prostate tissues from the Li‐ESWT group compared with those from the EAP group (all <i>P</i> < 0.05). Similarly, there was reduced pelvic pain and allergic symptoms in the Li‐ESWT group compared with the EAP group (all <i>P</i> < 0.05). Besides, Li‐ESWT treatment could decrease oxidative stress in the prostate and in RWPE‐1 cells, respectively (both <i>P</i> < 0.05). Moreover, the Li‐ESWT up‐regulated the expression of CAT through the inhibition of phosphorylation of AKT/FOXO1 signaling pathway. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Discussion and Conclusions</h3><p>Li‐ESWT may reduce inflammation, oxidative stress and pain in rats with autoimmunity‐induced prostatitis via the PI3K/AKT/FOXO1 pathway. It implies that Li‐ESWT can present a potential therapeutic option for the treatment of CP/CPPS.</p></section>

Isoliquiritigenin reduces experimental autoimmune prostatitis by facilitating Nrf2 activation and suppressing the NLRP3 inflammasome pathway

4-Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome-induced pyroptosis through activating Nrf2/HO-1 pathway

Isoliquiritigenin, A Natural Anti-Oxidant, Selectively Inhibits the Proliferation of Prostate Cancer Cells

Hedyotis diffusa Willd inhibits inflammation and oxidative stress to protect against chronic prostatitis via the NRF2/ARE signaling pathway

Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway

Isoliquiritigenin alleviates neuropathic pain by reducing microglia inflammation through inhibition of the ERK signaling pathway and decreasing CEBPB transcription expression

Anti-inflammatory Effect and Prostate Gene Expression Profiling of Steryl Ferulate on Experimental Rats with Non-Bacterial Prostatitis

Li‐ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models

New Therapy with XLQ® to Suppress Chronic Prostatitis Through Its Anti‐inflammatory and Antioxidative Activities

Quercetin Protects Against Chronic Prostatitis in Rat Model Through NF‐κB and MAPK Signaling Pathways

N-acetylcysteine Ameliorates Prostatitis via miR-141 Regulating Keap1/Nrf2 Signaling

Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats

MIF aggravates experimental autoimmune prostatitis through activation of the NLRP3 inflammasome via the PI3K/AKT pathway

Shuangshi Tonglin capsule improves chronic prostatitis through the SIRT-1/AMPK and MAPK signalling pathways

Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-B, MAPKs, and Nrf2 signaling pathways in rats

Isoliquiritigenin inhibits microglia‐mediated neuroinflammation in models of Parkinson's disease via JNK/AKT/NFκB signaling pathway

Isoliquiritigenin Activates Nuclear Factor Erythroid-2 Related Factor 2 to Suppress the NOD-Like Receptor Protein 3 Inflammasome and Inhibits the NF-κB Pathway in Macrophages and in Acute Lung Injury

Lycopene attenuates CP/CPPS by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs and Nrf2 signaling pathways in rats.

Astaxanthin Alleviates Chronic Prostatitis via the ERK1/2 Signaling Pathway: Evidence from Network Pharmacology and Experimental Validation

Isoliquiritigenin ameliorates caerulein-induced chronic pancreatitis by inhibiting the activation of PSCs and pancreatic infiltration of macrophages.

The aryl hydrocarbon receptor agonist ITE reduces inflammation and urinary dysfunction in a mouse model of autoimmune prostatitis